USPSTF recommendation statement on screening for obstructive sleep apnea in adults JAMA

he U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to make a recommendation about screening for obstructive sleep apnea (OSA) in the general adult population. This statement applies to asymptomatic adults and adults with unrecognized symptoms of OSA. Current prevalence of OSA in the United States is not well established. In 2007-2010 the estimated prevalence of at least mild OSA plus symptoms of daytime sleepiness among adults ages 30 to 70 was 14% for men and 5% for women, and the estimated prevalence of moderate to severe OSA was 13% for men and 6% for women. Adverse health outcomes associated with untreated OSA include cardiovascular disease and cerebrovascular events, type 2 diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. Severe OSA is associated with increased all-cause mortality. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this statement is consistent with its 2017 recommendation on screening for OSA.